You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API topotecan hydrochloride

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing topotecan hydrochloride

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	HYCAMTIN	topotecan hydrochloride	0078-0674	HYDROCHLORIC ACID
Novartis Pharmaceuticals Corporation	HYCAMTIN	topotecan hydrochloride	0078-0674	MANNITOL
Novartis Pharmaceuticals Corporation	HYCAMTIN	topotecan hydrochloride	0078-0674	SODIUM HYDROXIDE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing topotecan hydrochloride

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Accord Healthcare Inc	topotecan hydrochloride	16729-151	HYDROCHLORIC ACID
Accord Healthcare Inc	topotecan hydrochloride	16729-151	MANNITOL
Accord Healthcare Inc	topotecan hydrochloride	16729-151	SODIUM HYDROXIDE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for topotecan hydrochloride

Excipient focus: HYDROCHLORIC ACID

topotecan hydrochloride drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	topotecan hydrochloride	0078-0674
Accord Healthcare Inc	topotecan hydrochloride	16729-151
Actavis Pharma Inc	topotecan hydrochloride	45963-615
>Company	>Ingredient	>NDC

topotecan hydrochloride drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

topotecan hydrochloride drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	topotecan hydrochloride	0078-0674
Accord Healthcare Inc	topotecan hydrochloride	16729-151
Actavis Pharma Inc	topotecan hydrochloride	45963-615
>Company	>Ingredient	>NDC

topotecan hydrochloride drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

topotecan hydrochloride drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	topotecan hydrochloride	0078-0674
Accord Healthcare Inc	topotecan hydrochloride	16729-151
Actavis Pharma Inc	topotecan hydrochloride	45963-615
>Company	>Ingredient	>NDC

topotecan hydrochloride drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TARTARIC ACID

topotecan hydrochloride drug variants containing TARTARIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	topotecan hydrochloride	0078-0674
Accord Healthcare Inc	topotecan hydrochloride	16729-151
Actavis Pharma Inc	topotecan hydrochloride	45963-615
>Company	>Ingredient	>NDC

topotecan hydrochloride drug variants not containing TARTARIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.